IL129535A - Method of diagnosing bone dysbolism - Google Patents

Method of diagnosing bone dysbolism

Info

Publication number
IL129535A
IL129535A IL12953598A IL12953598A IL129535A IL 129535 A IL129535 A IL 129535A IL 12953598 A IL12953598 A IL 12953598A IL 12953598 A IL12953598 A IL 12953598A IL 129535 A IL129535 A IL 129535A
Authority
IL
Israel
Prior art keywords
ocif
antibodies recognizing
arthrosis
concentration
monoclonal antibodies
Prior art date
Application number
IL12953598A
Other languages
English (en)
Other versions
IL129535A0 (en
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL129535A0 publication Critical patent/IL129535A0/xx
Publication of IL129535A publication Critical patent/IL129535A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
IL12953598A 1997-09-24 1998-07-31 Method of diagnosing bone dysbolism IL129535A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27647597 1997-09-24
PCT/JP1998/003421 WO1999015691A1 (en) 1997-09-24 1998-07-31 Method for diagnosing bone dysbolism

Publications (2)

Publication Number Publication Date
IL129535A0 IL129535A0 (en) 2000-02-29
IL129535A true IL129535A (en) 2003-07-06

Family

ID=17569976

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12953598A IL129535A (en) 1997-09-24 1998-07-31 Method of diagnosing bone dysbolism

Country Status (16)

Country Link
US (2) US6693175B2 (de)
EP (1) EP0974671B1 (de)
JP (1) JP4268684B2 (de)
KR (1) KR100547395B1 (de)
CN (1) CN1183159C (de)
AT (1) ATE328281T1 (de)
AU (1) AU739304B2 (de)
CA (1) CA2269114A1 (de)
DE (1) DE69834719D1 (de)
HU (1) HUP0002062A3 (de)
IL (1) IL129535A (de)
NO (1) NO992472D0 (de)
NZ (1) NZ335759A (de)
RU (1) RU2203497C2 (de)
WO (1) WO1999015691A1 (de)
ZA (1) ZA986974B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
HUP0104126A3 (en) * 1998-10-28 2004-07-28 Sankyo Company Ltd Chuo Ku Remedies for bone metabolic errors
JP3709332B2 (ja) * 2000-09-14 2005-10-26 株式会社エーシーバイオテクノロジーズ 骨粗鬆症の診断および／または骨粗鬆症骨折リスクの予測の方法
WO2002062990A1 (fr) * 2001-02-07 2002-08-15 Sankyo Company, Limited Anticorps et utilisation de cet anticorps
WO2002079256A1 (fr) * 2001-03-26 2002-10-10 Sankyo Company, Limited Anticorps et son utilisation
JP4921687B2 (ja) 2001-04-03 2012-04-25 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 乳中の破骨細胞分化抑制因子
EP1270015A3 (de) * 2001-06-29 2004-02-25 Sankyo Company Limited Ein Komplex enthaltend OCIF und einem Polysaccharid
EP1482978A1 (de) * 2002-03-01 2004-12-08 Sankyo Company, Limited Pharmazeutische zusammensetzung enthaltend osteoklastogenesishemmungsfaktor
US7279451B2 (en) 2002-10-25 2007-10-09 Honeywell International Inc. Compositions containing fluorine substituted olefins
AU2002343870A1 (en) * 2002-11-07 2004-06-07 Kumamoto Technology And Industry Foundation Transgenic mammal carrying ganp and utilization thereof
KR100545064B1 (ko) * 2003-05-26 2006-01-24 김현기 인간 원암단백질에 특이적인 항체를 포함하는 간경변증진단 키트
RU2261661C1 (ru) * 2004-02-11 2005-10-10 Белых Елена Викторовна Способ прогнозирования переломов кости у женщин, больных ревматоидным артритом
RU2268655C2 (ru) * 2004-03-09 2006-01-27 Государственное учреждение "Нижегородский научно-исследовательский институт гигиены и профпатологии Министерства здравоохранения Российской Федерации" Способ оценки риска развития аллергодерматозов
RU2271007C2 (ru) * 2004-04-28 2006-02-27 Дмитрий Владимирович Пешехонов Способ исследования сыворотки крови для фармакологической коррекции при остеопорозе
KR101414064B1 (ko) * 2006-05-17 2014-07-01 더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕 세포 배양액 중의 세포의 운명에 영향을 미치는 방법
RU2358655C2 (ru) * 2007-08-20 2009-06-20 Федеральное государственное учреждение "Уральский научно-исследовательский институт травматологии и ортопедии им. В.Д. Чаклина" Федерального агентства по высокотехнологичной медицинской помощи" Способ диагностики иммобилизационного остеопороза
RU2429476C1 (ru) * 2010-04-22 2011-09-20 Государственное учреждение Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского (ГУ МОНИКИ им. М.Ф. Владимирского) Способ диагностики артроза
WO2012051495A2 (en) 2010-10-15 2012-04-19 The Research Foundation Of State University Of New York Compositions and methods for enhancing the biological response to chemical agents and physical stimuli
RU2524616C1 (ru) * 2013-01-21 2014-07-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Владивостокский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГОУ ВПО ВГМУ Минздрава России) Способ диагностики ранней стадии ревматоидного артрита
GB201302257D0 (en) 2013-02-08 2013-03-27 Nobel Biocare Services Ag Method for measuring bone loss rate
CN106405064B (zh) * 2016-08-30 2018-10-26 嘉兴行健生物科技有限公司 一种40岁以上女性骨转换率的评估方法
CN109540818A (zh) * 2018-12-21 2019-03-29 云南农业大学 一种基于钙、磷血液生化标记选育武定鸡的方法
CN113621060B (zh) * 2020-05-07 2023-07-04 浙江瑞硕生物技术有限公司 一种opg抗体对及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
WO1990004417A1 (en) * 1988-10-24 1990-05-03 Bruce Caterson Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis
EP0513334A4 (en) 1990-11-30 1993-08-04 Celtrix Laboratories, Inc. Use of a bone morphogenetic protein in synergistic combination with tgf--g(b) for bone repair
US5118667A (en) 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
CA2068389A1 (en) 1991-05-13 1992-11-14 Masahiko Sato Method for inhibiting bone resorption
MX9204303A (es) 1991-07-23 1993-11-01 Rhone Poulenc Rorer Int Factor regulador del crecimiento de osteoclasto.
US5366859A (en) * 1991-10-31 1994-11-22 Mitsubishi Petrochemical Co., Ltd. Radioimmunoassay method
US5447851B1 (en) 1992-04-02 1999-07-06 Univ Texas System Board Of Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
US5427954A (en) * 1992-04-29 1995-06-27 Shriner's Hospitals For Crippled Children Compositions and methods for detection and treatment of human osteoarthritis
RU2046600C1 (ru) * 1992-07-28 1995-10-27 Саратовский научно-исследовательский институт травматологии и ортопедии Способ диагностики травматических повреждений тазобедренного сустава
US5578569A (en) 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
ATE202571T1 (de) 1993-09-14 2001-07-15 Merck & Co Inc Humane protein-tyrosinphosphatase decodierende cdna
US6046033A (en) * 1994-06-27 2000-04-04 Snow Brand Milk Products Co., Ltd. Basic osteoblast growth factor II (bOGF-II)
AU4440496A (en) 1995-02-10 1996-08-22 Smithkline Beecham Corporation Use of src SH2 specific compounds to treat a bone resorption disease
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
WO1996028546A1 (en) 1995-03-15 1996-09-19 Human Genome Sciences, Inc. Human tumor necrosis factor receptor
AU5985996A (en) 1995-06-07 1997-01-15 Osteosa Inc. Osteoclast growth regulatory factor
WO1997000318A1 (en) * 1995-06-07 1997-01-03 Osteosa Inc. Osteoclast growth regulatory factor
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
US6613544B1 (en) * 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
JPH1057071A (ja) 1996-08-19 1998-03-03 Snow Brand Milk Prod Co Ltd 新規ｄｎａ及びそれを用いた蛋白質の製造方法
US5830850A (en) * 1996-08-28 1998-11-03 Mount Sinai School Of Medicine Of The City Of New York Methods for the treatment of bone resorption disorders, including osteoporosis
AU5901598A (en) 1996-12-20 1998-07-17 Board Of Regents, The University Of Texas System Compositions and methods of use for osteoclast inhibitory factors
US6242213B1 (en) 1996-12-23 2001-06-05 Immunex Corporation Isolated DNA molecules encoding RANK-L
US5843678A (en) 1997-04-16 1998-12-01 Amgen Inc. Osteoprotegerin binding proteins

Also Published As

Publication number Publication date
RU2203497C2 (ru) 2003-04-27
ATE328281T1 (de) 2006-06-15
US20020004207A1 (en) 2002-01-10
IL129535A0 (en) 2000-02-29
EP0974671A4 (de) 2004-10-22
EP0974671B1 (de) 2006-05-31
CA2269114A1 (en) 1999-03-24
HUP0002062A2 (hu) 2000-10-28
ZA986974B (en) 1999-02-04
EP0974671A8 (de) 2002-07-03
DE69834719D1 (de) 2006-07-06
NZ335759A (en) 2002-02-01
US6693175B2 (en) 2004-02-17
HUP0002062A3 (en) 2002-09-30
US20040033533A1 (en) 2004-02-19
CN1183159C (zh) 2005-01-05
KR100547395B1 (ko) 2006-02-01
AU8461798A (en) 1999-04-12
NO992472L (no) 1999-05-21
JP4268684B2 (ja) 2009-05-27
WO1999015691A1 (en) 1999-04-01
US6998242B2 (en) 2006-02-14
AU739304B2 (en) 2001-10-11
NO992472D0 (no) 1999-05-21
KR20000068916A (ko) 2000-11-25
CN1239515A (zh) 1999-12-22
EP0974671A1 (de) 2000-01-26

Similar Documents

Publication Publication Date Title
IL129535A (en) Method of diagnosing bone dysbolism
ES2014540A6 (es) Metodo para la determinacion de fragmentos peptidicos con un entrecruzamiento 3-hidroxipiridinio en un fluido corporal.
HK1002814A1 (zh) 金蓮燈t之特別抗體，其生產及在測定心臟肌肉壞疽試劑中的使用
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
ATE153701T1 (de) Immunchromatographischer assay und verfahren zur nutzung desselben
EP0379949A3 (de) Verfahren zur Bestimmung von HIV-Antikörpern
EP0407904A3 (en) Method for the determination of an analyte
RU99113447A (ru) Способ диагностики метаболических костных заболеваний
EP0869177A3 (de) Menschliche Typ-A und Typ-B Blutplättchen abstammenden Wachstumfaktor Rezeptoren
GB9507985D0 (en) Antibody to aminoterminal propeptide to type 1 procollagen and assay method using it
AU635243B2 (en) Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
AU657719B2 (en) Methods for determination of an analyte
ATE180894T1 (de) Verwendung von polyklonalen humanen anti-htg- autoantikörpern als reagenz für die klinische diagnostik von schilddrüsen-autoimmunerkrankungen sowie reagenziensatz für eine bestimmung von anti-htg-autoantikörpern in patientenseren
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
WO1994003814A3 (en) Method and kit for pyridinium crosslink assay
WO1990008956A1 (en) Detection of human tissue factor activator
AU4692199A (en) Cartilage resorption assays
CA2081879A1 (en) Monoclonal antibodies to polyacrylate polymers
DK34393D0 (da) Humant foetalt antigen 1 (fa1), anvendelse af fa1 og anti-fa1 specifikke antistoffer som biologiske principper og immunoreagenser samt kvantitive teknikker baseret herpaa

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees